Treatment of benign prostatic hyperplasia
US6989400B2 · kind B2 · utility
5Cited by
10References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 16, 2004 |
| Grant date | Jan 24, 2006 |
| Priority date | — |
| Expiry date | Apr 7, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/342
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidamine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.